Christopher Lindberg

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis

Fredrik Piehl, Ann Eriksson‐Dufva, Anna Budzianowska et al. · JAMA Neurology · 2022 · 173 citations · Full text

Myosin storage myopathy associated with a heterozygous missense mutation in <i>MYH7</i>

Homa Tajsharghi, Lars‐Eric Thornell, Christopher Lindberg et al. · Annals of Neurology · 2003 · 155 citations

Polyglucosan body myopathy caused by defective ubiquitin ligase RBCK1

Johanna Nilsson, Benedikt Schoser, Pascal Laforêt et al. · Annals of Neurology · 2013 · 145 citations · Full text

Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double-blind, parallel-group, phase 3 trial

Benedikt Schoser, Mark Roberts, Barry J. Byrne et al. · The Lancet Neurology · 2021 · 124 citations

Clinical Trials, Cipaglucosidase Alfa, Pharmacotherapy +2